Showing results (351-360 of 383) with videos related to

Sort By:
Pageof 39
Journal of Affective Disorders|April 26, 2023
Case-controlled field study of the ICD-11 clinical descriptions and diagnostic requirements for Bodily Distress DisordersJared Keeley, Geoffrey M Reed, Tahilia Rebello, et al.
Journal of Perinatal Medicine|February 5, 2021
Clinical chorioamnionitis at term X: microbiology, clinical signs, placental pathology, and neonatal bacteremia - implications for clinical careRoberto Romero, Percy Pacora, Juan Pedro Kusanovic, et al.
International Journal of Molecular Sciences|September 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple SclerosisMaría Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal, et al.
Geroscience|October 24, 2023
Reversal of biological age in multiple rat organs by young porcine plasma fractionSteve Horvath, Kavita Singh, Ken Raj, et al.
Obesity (Silver Spring, Md.)|August 30, 2020
Genome-Wide Association Study in 3,173 Outbred Rats Identifies Multiple Loci for Body Weight, Adiposity, and Fasting GlucoseApurva S Chitre, Oksana Polesskaya, Katie Holl, et al.
The Lancet. Oncology|June 24, 2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trialGary Middleton, Paul Silcocks, Trevor Cox, et al.
Frontiers in Veterinary Science|July 23, 2025
Non-tuberculous mycobacteria and other acid fast bacilli pathogens identification by qPCR and MALDI-ToF MS in tuberculosis-like lesions of slaughtered cattle from EcuadorSolon Alberto Orlando, Leila Estefania Vera Loor, Joselyn Calderón, et al.
Cancer Discovery|December 2, 2016
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 MutationsDaniel Sanghoon Shin, Jesse M Zaretsky, Helena Escuin-Ordinas, et al.
British Journal of Cancer|August 10, 2016
L1CAM expression in endometrial carcinomas: an ENITEC collaboration studyLouis Jm van der Putten, Nicole Cm Visser, Koen van de Vijver, et al.
JAMA Oncology|May 13, 2021
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical TrialPeter S Hall, Daniel Swinson, David A Cairns, et al.
Pageof 39